Drug
Faster Acting Insulin Aspart
Faster Acting Insulin Aspart: highest development phase Phase 3, developed by Novo Nordisk. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| Faster-acting insulin aspart NCT01819129 | Phase 3 | Diabetes |
| Faster-acting insulin aspart NCT02933853 | Phase 1 | Diabetes |
Latest
No recent events.
Follow Faster Acting Insulin Aspart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.